| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 153, Issue 2 482-488, Copyright © 1994 by American Association of Immunologists
ARTICLES |
K Ando, LG Guidotti, A Cerny, T Ishikawa and FV Chisari
First Department of Internal Medicine, Gifu University School of Medicine, Japan.
MHC class I-restricted, hepatitis B surface Ag (HBsAg)-specific, CD8+ polyclonal CTL lines and clones cause a severe necroinflammatory liver disease when they are injected i.v. into transgenic mice that display widespread tissue expression of HBsAg. Surprisingly, the same CTLs fail to cause disease in any other HBsAg-positive tissue in these animals. However, the CTLs are highly cytopathic for HBsAg-positive renal tubules and choroid plexus epithelial cells when they are injected extravascularly, either beneath the kidney capsule or intracerebrally. Analysis of the microvascular anatomy of these tissues reveals that the hepatic sinusoid is characterized by a discontinuous endothelium and the absence of a basement membrane. In contrast, the vasculature of most other tissues displays a continuous endothelium and basement membrane; and the epithelial cells of many of these tissues are also surrounded by a separate basement membrane. These results suggest that viral, tumor, and normal self Ags expressed in the liver are readily accessible to class I-restricted T cells, whereas the vascular endothelium and/or the vascular and cellular basement membranes constitute an extremely effective barrier that precludes CTL access to tissue Ag at many other sites. Because class I-restricted Ag recognition occurs throughout the body in many natural diseases and disease models, the vascular barrier must be breached by other events before CTL access to endogenously synthesized epithelial Ag can occur.
This article has been cited by other articles:
|
|
 |
|
  A. E. Snook, B. J. Stafford, P. Li, G. Tan, L. Huang, R. Birbe, S. Schulz, M. J. Schnell, M. Thakur, J. L. Rothstein, et al. Guanylyl Cyclase C-Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity J Natl Cancer Inst, July 2, 2008; 100(13): 950 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ito, K. Ando, T. Ishikawa, T. Nakayama, M. Taniguchi, K. Saito, M. Imawari, H. Moriwaki, T. Yokochi, S. Kakumu, et al. Role of V{alpha}14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V{alpha}14+ NKT cells promotes the breakage of CTL tolerance Int. Immunol., July 1, 2008; 20(7): 869 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Lukens, M. W. Cruise, M. G. Lassen, and Y. S. Hahn Blockade of PD-1/B7-H1 Interaction Restores Effector CD8+ T Cell Responses in a Hepatitis C Virus Core Murine Model J. Immunol., April 1, 2008; 180(7): 4875 - 4884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takai, K. Kimura, M. Nagaki, S. Satake, K. Kakimi, and H. Moriwaki Blockade of Neutrophil Elastase Attenuates Severe Liver Injury in Hepatitis B Transgenic Mice J. Virol., December 15, 2005; 79(24): 15142 - 15150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Chen, N. Khanna, S. A. Stohlman, and C. C. Bergmann Virus-Specific and Bystander CD8 T Cells Recruited during Virus-Induced Encephalomyelitis J. Virol., April 15, 2005; 79(8): 4700 - 4708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Djilali-Saiah, P. Lapierre, S. Vittozi, and F. Alvarez DNA Vaccination Breaks Tolerance for a Neo-Self Antigen in Liver: A Transgenic Murine Model of Autoimmune Hepatitis J. Immunol., November 1, 2002; 169(9): 4889 - 4896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Horke, K. Reumann, A. Rang, and T. Heise Molecular Characterization of the Human La Protein{middle dot}Hepatitis B Virus RNA.B Interaction in Vitro J. Biol. Chem., September 13, 2002; 277(38): 34949 - 34958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Matthews, S. R. Weiss, M. J. Shlomchik, L. G. Hannum, J. L. Gombold, and Y. Paterson Antibody Is Required for Clearance of Infectious Murine Hepatitis Virus A59 from the Central Nervous System, But Not the Liver J. Immunol., November 1, 2001; 167(9): 5254 - 5263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Heise, L. G. Guidotti, and F. V. Chisari Characterization of Nuclear RNases That Cleave Hepatitis B Virus RNA near the La Protein Binding Site J. Virol., August 1, 2001; 75(15): 6874 - 6883. [Abstract] [Full Text]
|
|
|
|
|
|
W. Z. Mehal, F. Azzaroli, and I. N. Crispe Antigen Presentation by Liver Cells Controls Intrahepatic T Cell Trapping, Whereas Bone Marrow-Derived Cells Preferentially Promote Intrahepatic T Cell Apoptosis J. Immunol., July 15, 2001; 167(2): 667 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bertolino, D. G. Bowen, G. W. McCaughan, and B. Fazekas de St. Groth Antigen-Specific Primary Activation of CD8+ T Cells Within the Liver J. Immunol., May 1, 2001; 166(9): 5430 - 5438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Sette, C. Oseroff, J. Sidney, J. Alexander, R. W. Chesnut, K. Kakimi, L. G. Guidotti, and F. V. Chisari Overcoming T Cell Tolerance to the Hepatitis B Virus Surface Antigen in Hepatitis B Virus-Transgenic Mice J. Immunol., January 15, 2001; 166(2): 1389 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Marzo, B. F. Kinnear, R. A. Lake, J. J. Frelinger, E. J. Collins, B. W. S. Robinson, and B. Scott Tumor-Specific CD4+ T Cells Have a Major ""Post-Licensing"" Role in CTL Mediated Anti-Tumor Immunity J. Immunol., December 1, 2000; 165(11): 6047 - 6055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Voehringer, C. Blaser, A. B. Grawitz, F. V. Chisari, K. Buerki, and H. Pircher Break of T Cell Ignorance to a Viral Antigen in the Liver Induces Hepatitis J. Immunol., September 1, 2000; 165(5): 2415 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schirmbeck, J. Wild, D. Stober, H. E. Blum, F. V. Chisari, M. Geissler, and J. Reimann Ongoing Murine T1 or T2 Immune Responses to the Hepatitis B Surface Antigen Are Excluded from the Liver that Expresses Transgene-Encoded Hepatitis B Surface Antigen J. Immunol., April 15, 2000; 164(8): 4235 - 4243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bertolino, M.-C. Trescol-Biemont, J. Thomas, B. F. de St Groth, M. Pihlgren, J. Marvel, and C. Rabourdin-Combe Death by neglect as a deletional mechanism of peripheral tolerance Int. Immunol., August 1, 1999; 11(8): 1225 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Heise, L. G. Guidotti, and F. V. Chisari La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA J. Virol., July 1, 1999; 73(7): 5767 - 5776. [Abstract] [Full Text]
|
|
|
|
|
|
T. Heise, L. G. Guidotti, V. J. Cavanaugh, and F. V. Chisari Hepatitis B Virus RNA-Binding Proteins Associated with Cytokine-Induced Clearance of Viral RNA from the Liver of Transgenic Mice J. Virol., January 1, 1999; 73(1): 474 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Stohlman, C. C. Bergmann, M. T. Lin, D. J. Cua, and D. R. Hinton CTL Effector Function Within the Central Nervous System Requires CD4+ T Cells J. Immunol., March 15, 1998; 160(6): 2896 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Kajon, C. C. Brown, and K. R. Spindler Distribution of Mouse Adenovirus Type 1 in Intraperitoneally and Intranasally Infected Adult Outbred Mice J. Virol., February 1, 1998; 72(2): 1219 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Song, V. Lee, C. D. Surh, A. Lynn, D. Brumm, D. J. Jolly, J. F. Warner, and S. Chada Antigen presentation in retroviral vector-mediated gene transfer in vivo PNAS, March 4, 1997; 94(5): 1943 - 1948. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
